INSERM NeuroTechnologies

INSERM's NeuroTechnologies impulse programme was officially launched on 12 April 2024! The "Probing & Modulating the Brain Activity" project will enable the team to develop stimulation projects targeting the cerebellum on the CEMNIS platform, with new collaborations (Charalambos Papaxanthis, Charlotte Rosso, Marion Plaze, Jean-François Aubry). L…

[Translate to English:]

Formal establishment of the INSERM UMR-S 1329 unit

INSERM unit UMR-S 1329, the result of the merger of ex-UMR-S 1114 & 1118, officially takes office on January 1st, 2024. This new INSERM multi-team is headed by Luc Dupuis and co-directed by Anne Giersch (Pychiatry team), Laurence Lalanne & Emmanuel Darcq (Addictions team) and Caroline Rouaux (ALS-FTD team).

News

New illusion

The team has developed a new illusion that allows us to explore sensory predictions that we don't even know exist.

Publications

New genes linked to ALS

Work by Luc Dupuis' team has shown direct links between the genetics and anatomopathology of amyotrophic lateral sclerosis (ALS or Lou Gehrig's…

About STEP

This jointly labelled research unit (UMR-S), established by INSERM and the University of Strasbourg, emerged from the integration of the former UMR-S 1114 (Kieffer & Giersch's lab) and UMR-S 1118 (Dupuis's lab).

Its main mission is the integration of the expertise of the three teams and the bridging of knowledge within this research unit.

The recently appointed Head of the Department is Dr Luc Dupuis, assisted by the co-directors of the teams within STEP, Dr Giersch for the Psychiatry team, Dr Lalanne & Dr Darcq for the Addictions team and Dr Rouaux for the ALS-FTD team.

For more detailed explanations on our teams, please visit their respective presentation page.